Skip to main content
SpringerLink
Log in

Proton therapy for uveal melanomas and other eye lesions

  • Clinical Aspects of Hadron Therapy
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

Abstract

Charged particle beams are ideal for treating intra-ocular lesions, since they can be made to deposit their dose in the target, while significantly limiting dose received by non-involved ocular and orbital structures. Proton beam treatment of large numbers of uveal melanoma patients consistently achieves local control rates in excess of 95%, and eye retention rates of approximately 90%. Visual preservation is related to initial visual acuity, tumor size and location, and dose received by the macula, disc, and lens. The probability of distant metastasis is increased by larger tumor diameter, more anterior tumor location, and older patient age. Proton therapy is also effective treatment for patients with ocular angiomas, hemangiomas, metastatic tumors, and retinoblastomas, and may be beneficial for patients with exudative (“wet”) age-related macular degeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stallard HB. Malignant melanoblastoma of the choroid. Mod Prob Ophthalmol 1966;7:16–38.

    Google Scholar 

  2. Cruess AF, Augsburger JJ, Shields JA, et al. Visual results following Cobalt plaque radiotherapy for posterior uveal melanomas. Ophthalmol 1984;91:131–6.

    CAS  Google Scholar 

  3. Garretson BR, Robertson DM, Earle JK. Choroidal melanoma treatment with iodine-125 brachytherapy. Arch Ophthalmol 1987;105:1394–7.

    PubMed  CAS  Google Scholar 

  4. Lommatzsch PK. Beta-irradiation of choroidal melanoma with 106Ru/ 106Rh applicators. Arch Ophthalmol 1983;101:713–7.

    PubMed  CAS  Google Scholar 

  5. Marcoe AM, Brady LW, Shields J, et al. Radioactive eye plaque therapy versus enucleation for the treatment of posterior uveal malignant melanoma. Radiology 1985;156:801–3.

    Google Scholar 

  6. Rotman M, Long RS, Packer S, et al. Radiation therapy of uveal melanomas. Trans Ophthalmol Soc UK 1977;97:431–5.

    PubMed  CAS  Google Scholar 

  7. Brovkina, AF, Zarubei GD. Ciliochoroidal melanomas treated with a narrow medical proton beam. Arch Ophthalmol 1986;104:402–4.

    PubMed  CAS  Google Scholar 

  8. Char DH, Castro JR, Kroll SM, et al. Five-year follow-up of helium ion therapy for uveal melanoma. Ophthalmol 1990;108:209–14.

    CAS  Google Scholar 

  9. Bonnet DE, Kacperek A, Sheen MA, et al. The 62 MeV proton beam for the treatment of ocular melanoma at Clatterbridge. Br J Radiol 1993;66: 907–14.

    Article  Google Scholar 

  10. Gragoudas ES, Seddon JM, Egan K, et al. Long-term results of proton beam irradiated uveal melanomas. Arch Ophthalmol 1987;94:349–53.

    CAS  Google Scholar 

  11. Zografos L, Perret C, Egger E, et al. Proton Beam Irradiation of Uveal Melanomas at Paul Scherrer Institute (former SIN). Strahlenther Onkol 1990;166:114.

    PubMed  CAS  Google Scholar 

  12. Castro JR, Char DH, Petti PL, et al. 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiation Oncology Biol Phys 1997;39:989–96.

    CAS  Google Scholar 

  13. Tsunemoto H, Morita S, Kawachi K, et al. Clinical results of proton radiotherapy in Japan. Proceedings of the 8th International Cong of Rad Research. Edinburgh, 1987, pp. 922–7.

  14. Daftari IK, Char DH, Verhey LJ, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiation Oncology Biol Phys 1997;39:997–1010.

    CAS  Google Scholar 

  15. Slater JM, Archambeau JO, Miller DW, et al. The proton treatment center at Loma Linda University Medical Center: Rationale for and description of its development. Int J Radiat Oncol Biol Phys 1992;22:383–9.

    PubMed  CAS  Google Scholar 

  16. Archambeau JO, Mao XW, Yonemoto LT, et al. What is the role of radiation in the treatment of subfoveal membranes: Review of radiobiologic, pathologic, and other considerations to initiate a multimodality discussion. Int J Radiat Oncol Biol Phys 1998;40:1125–36.

    PubMed  CAS  Google Scholar 

  17. Castro JR, Petti PL, Blakely EA, et al. Particle Radiation Therapy. In: Leibel SA, Phillips TL (eds.). Textbook of Radiotherapy. New York: W B Saunders, 1998.

    Google Scholar 

  18. Constable IJ, Koehler AM, Schmidt RA. Proton irradiation of simulated ocular tumors. Investig Ophthalmol 1975;14:547–55.

    CAS  Google Scholar 

  19. Constable IJ, Goitein M, Koehler AM, et al. Small field irradiation of monkey eyes with protons and photons. Radiation Research 1976;65: 304–14.

    Article  PubMed  CAS  Google Scholar 

  20. Gragoudas ES, Zakov NZ, Albert DM, et al. Long term observations of proton-irradiated monkey eyes. Arch Ophthalmol 1979;97:2184–91.

    PubMed  CAS  Google Scholar 

  21. The Collaborative Ocular Melanoma Study Group. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS Report No. 1. Ophthalmol 1990;108:1268–73.

    Google Scholar 

  22. Goitein M, Miller T. Planning proton therapy of the eye. Med Phys 1983; 10:275–83.

    Article  PubMed  CAS  Google Scholar 

  23. Gragoudas ES, Goitein M, Koehler AM, et al. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol 1977;83:655–73.

    Google Scholar 

  24. Gragoudas ES, Goitein M, Verhey LJ, et al. Proton beam irradiation. An alternative to enucleation for intraocular melanoma. Ophthalmol 1980;87: 571–81.

    CAS  Google Scholar 

  25. Verhey LJ, Goitein M, Munzenrider JE, et al. Precise positioning of patients for radiation therapy. Int J Radiat Oncol Biol 1982;8:289–94.

    Article  CAS  Google Scholar 

  26. Urano M, Goitein M, Verhey LJ, et al. Relative biological effectiveness of modulated proton beams in various murine tissues. Int J Radiat. Oncol Biol Phys 1984;10:509–14.

    PubMed  CAS  Google Scholar 

  27. Yashkin PN, Silin DI, Zolotov VA, et al. Relative biological effectiveness of proton medical beam at Moscow Synchotron determined by the Chinese Hamster Cells assay. Int J Radiat Oncol Biol Phys 1995;31:535–40.

    PubMed  CAS  Google Scholar 

  28. Miller DW. A review of proton beam radiotherapy. Med Phys 1995;22: 1943–54.

    Article  PubMed  CAS  Google Scholar 

  29. Munzenrider JE, Verhey L, Gragoudas ES, et al. Conservative treatment of uveal melanoma: Dose distribution to tumors with local recurrence after proton beam therapy. Int J Radiation Oncology Biol Phys 1989;17: 493–8.

    CAS  Google Scholar 

  30. Gragoudas ES, Seddon JM, Polivogianis LL, et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmol 1986;93:675–80.

    CAS  Google Scholar 

  31. Gragoudas ES, Seddon JM, Egan KM, et al. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmol 1988;95:992–9.

    CAS  Google Scholar 

  32. Seddon JM, Gragoudas ES, Albert DM, et al. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 1985;99:282–90.

    PubMed  CAS  Google Scholar 

  33. Seddon JM, Gragoudas ES, Egan KM, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmol 1990;97:769–77.

    CAS  Google Scholar 

  34. Seddon JM, Albert DM, Lavin P, et al. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983;101:1894–9.

    PubMed  CAS  Google Scholar 

  35. Egan K, Gragoudas ES, Seddon JM, et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmol 1989;96:1377–83.

    CAS  Google Scholar 

  36. Ferry AP, Blair, CJ, Gragoudas ES, et al. Pathologic examination of ciliary body melanoma treated with proton beam irradiation. Arch Ophthalmol 1985;103:1849–53.

    PubMed  CAS  Google Scholar 

  37. Kincaid MC, Folberg R, Torczynski E, et al. Complications after proton beam therapy for uveal malignant melanoma. Ophthalmol 1988;95:982–91.

    CAS  Google Scholar 

  38. Seddon JM, Gragoudas ES, Albert DM. Ciliary body and choroidal melanomas treated by proton beam irradiation: Histopathologic study of eyes. Arch Ophthalmol 1983;101:1402–8.

    PubMed  CAS  Google Scholar 

  39. Zinn KM, Stein/Pokorny K, Jakobiec F, et al. Proton beam irradiated epithelial cell melanoma of the ciliary body. Ophthalmol 1981;88:1315–21.

    CAS  Google Scholar 

  40. Egan KM, Ryan LM, Gragoudas ES. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma. An example of regression on time-dependent covariates. Arch Ophthalmol 1998;116:366–70.

    PubMed  CAS  Google Scholar 

  41. Gragoudas ES, Egan KM, Arrigg PG, et al. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol 1992;110:475–9.

    PubMed  CAS  Google Scholar 

  42. Gragoudas ES, Egan KM, Walsh SM, et al. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol 1995;119:157–64.

    PubMed  CAS  Google Scholar 

  43. Seddon JM, Gragoudas ES, Polivogianis L, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmol 1986;93:666–74.

    CAS  Google Scholar 

  44. Seddon JM, Gragoudas ES, Egan KM, et al. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmol 1987;94:354–61.

    CAS  Google Scholar 

  45. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon Alpha-2b adjuvant therapy of high risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7–17.

    PubMed  CAS  Google Scholar 

  46. Char DH, Quivey JM, Castro JR, et al. Helium Ions versus Iodine-125 brachytherapy in the management of uveal melanoma, a prospective randomized dynamically balanced trial. Ophthalmology 1993;100:1547–54.

    PubMed  CAS  Google Scholar 

  47. American Academy of Ophthalmology. Age-related macular degeneration and choroidal neovascularization. American Academy of Ophthalmology 1994 (monograph).

  48. Smith LM, Donaldson SS, Egbert PR, et al. Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol Biol Phys 1989;17:499–505.

    PubMed  CAS  Google Scholar 

  49. Wong FL, Boice JD, Abramson DH, et al. Cancer incidence after retino-blastoma. Radiation dose and sarcoma risk. J Amer Med Soc 1998;278: 1262–7.

    Google Scholar 

  50. Kaste SC, Chen G, Fontanesi J, et al. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol 1997;15:1183–9.

    PubMed  CAS  Google Scholar 

  51. Goitein M, Abrams M. Multi-dimensional treatment planning: 1. Delineation of anatomy. Int J Radiat Oncol Biol Phys 1983;9:777–87.

    PubMed  CAS  Google Scholar 

  52. Goitein M, Abrams M, Rowell D, et al. Multi-dimensional treatment planning: II. Beam’s eye-view, back projection and projection through CT sections. Int J Radiat Oncol Biol. Phys 1993;9:789–97.

    Google Scholar 

  53. Urie M, Goitein M, Wagner M. Compensating for heterogeneities in proton radiation therapy. Phys Med Biol 1983;29:553–66.

    Article  Google Scholar 

  54. Mukai S. Management of retinoblastoma. Sem in Ophthalmol 1993;8: 281–91.

    Article  Google Scholar 

  55. Urie M, Goitein M. Variable versus fixed modulation of proton beams for treatment in the cranium. Med Phys 1989;16:593.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Harvard University Medical School, Massachusetts General Hospital, 02114, Boston, MA

    John E. Munzenrider MD

Authors
  1. John E. Munzenrider MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Munzenrider, J.E. Proton therapy for uveal melanomas and other eye lesions. Strahlenther Onkol 175 (Suppl 2), 68–73 (1999). https://doi.org/10.1007/BF03038893

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03038893

Key Words

Search

Navigation